Daiki Karigane
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daiki Karigane has a total of 135 co-authors. Here are the top co-authors by number of shared publications:
- Amy C. Fan
University of California San Francisco 4 Department of Pathology San Francisco, CA
30 shared publications - Ravindra Majeti
Department of Medicine, Division of Hematology, Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, USA
30 shared publications - Yusuke Nakauchi
Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
30 shared publications - Thomas Köhnke
Stanford University 1 Division of Hematology, Department of Medicine, Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine Stanford, California
29 shared publications - Yang Feng
Stanford University 1 Division of Hematology, Department of Medicine, Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine Stanford, California
24 shared publications - Fabian P. Suchy
Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA
23 shared publications
Latest Publications
- Open Access
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Data S5 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
Plots of top 100 DMRs (by area statistic & FWER) between DNMT3AR882H/WT re-mutated and DNMT3AWT/WT samples for AML-derived iPSC iSU444 at 8 months
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data S5 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
Plots of top 100 DMRs (by area statistic & FWER) between DNMT3AR882H/WT re-mutated and DNMT3AWT/WT samples for AML-derived iPSC iSU444 at 8 months
- Open Access
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
DMRs between DNMT3AR882H re-mutated and DNMT3AWT corrected blasts for patients SU372C, SU540, and SU575; and for AML-derived iPSC iSU444
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
DMRs between DNMT3AR882H re-mutated and DNMT3AWT corrected blasts for patients SU372C, SU540, and SU575; and for AML-derived iPSC iSU444
- Open Access
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S8 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
Enrichment of upstream regulators in DMR-associated genes and differentially expressed genes from Ingenuity Pathway Analysis
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S8 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
Enrichment of upstream regulators in DMR-associated genes and differentially expressed genes from Ingenuity Pathway Analysis
- Open Access
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Data S6 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
Plots of top 100 DMRs (by area statistic & FWER) between DNMT3AR882H/WT re-mutated and DNMT3AWT/WT samples for patient SU372C at 8 months
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data S6 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
Plots of top 100 DMRs (by area statistic & FWER) between DNMT3AR882H/WT re-mutated and DNMT3AWT/WT samples for patient SU372C at 8 months
- Open Access
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
Summary of DMRs between DNMT3AR882H re-mutated and DNMT3AWT corrected blasts for patients SU372C, SU540, and SU575; and for AML-derived iPSC iSU444
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
Summary of DMRs between DNMT3AR882H re-mutated and DNMT3AWT corrected blasts for patients SU372C, SU540, and SU575; and for AML-derived iPSC iSU444
- Open Access
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
FACS staining panels used in this study
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
FACS staining panels used in this study
- Open Access
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
Genes mapping to DMRs significant between DNMT3AR882H re-mutated and DNMT3AWT corrected blasts in all three patients (SU372C, SU540, and SU575)
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
Genes mapping to DMRs significant between DNMT3AR882H re-mutated and DNMT3AWT corrected blasts in all three patients (SU372C, SU540, and SU575)
- Open Access
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Data S1 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
Plots of top 100 DMRs (by area statistic & FWER) between DNMT3AR882H/WT re-mutated and DNMT3AWT/WT samples for patient SU372C at 4 months
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data S1 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
Plots of top 100 DMRs (by area statistic & FWER) between DNMT3AR882H/WT re-mutated and DNMT3AWT/WT samples for patient SU372C at 4 months
- Open Access
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
Overlap between DMRs (DNMT3AR882H/WT versus DNMT3AWT/WT) and DNA methylation canyons, stratified by patient and canyon type
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
Overlap between DMRs (DNMT3AR882H/WT versus DNMT3AWT/WT) and DNA methylation canyons, stratified by patient and canyon type
- Open Access
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S7 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
Putative blocks between DNMT3AR882H re-mutated and DNMT3AWT corrected blasts for patients SU372C, SU540, and SU575 at 4 months post-correction
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S7 from DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency
Putative blocks between DNMT3AR882H re-mutated and DNMT3AWT corrected blasts for patients SU372C, SU540, and SU575 at 4 months post-correction